Literature DB >> 16939737

The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants.

Haresh Kirpalani1, Robin K Whyte, Chad Andersen, Elizabeth V Asztalos, Nancy Heddle, Morris A Blajchman, Abraham Peliowski, Angel Rios, Meena LaCorte, Robert Connelly, Keith Barrington, Robin S Roberts.   

Abstract

OBJECTIVE: To determine whether extremely low birth weight infants (ELBW) transfused at lower hemoglobin thresholds versus higher thresholds have different rates of survival or morbidity at discharge. STUDY
DESIGN: Infants weighing <1000 g birth weight were randomly assigned within 48 hours of birth to a transfusion algorithm of either low or high hemoglobin transfusion thresholds. The composite primary outcome was death before home discharge or survival with any of either severe retinopathy, bronchopulmonary dysplasia, or brain injury on cranial ultrasound. Morbidity outcomes were assessed, blinded to allocation.
RESULTS: Four hundred fifty-one infants were randomly assigned to low (n = 223) or high (n = 228) hemoglobin thresholds. Groups were similar, with mean birth weight of 770 g and gestational age of 26 weeks. Fewer infants received one or more transfusions in the low threshold group (89% low versus 95% high, P = .037). Rates of the primary outcome were 74.0% in the low threshold group and 69.7% in the high (P = .25; risk difference, 2.7%; 95% CI -3.7% to 9.2%). There were no statistically significant differences between groups in any secondary outcome.
CONCLUSIONS: In extremely low birth weight infants, maintaining a higher hemoglobin level results in more infants receiving transfusions but confers little evidence of benefit.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16939737     DOI: 10.1016/j.jpeds.2006.05.011

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  119 in total

1.  Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants.

Authors:  R Singh; P F Visintainer; I D Frantz; B L Shah; K M Meyer; S A Favila; M S Thomas; D M Kent
Journal:  J Perinatol       Date:  2011-01-27       Impact factor: 2.521

Review 2.  Plasma-derived medicines: access and usage issues.

Authors:  Albert Farrugia; Josephine Cassar
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

3.  Functional echocardiographic assessment of myocardial performance in anemic premature infants: a pilot study.

Authors:  Maurizio Radicioni; Stefania Troiani; Daniele Mezzetti
Journal:  Pediatr Cardiol       Date:  2012-01-25       Impact factor: 1.655

Review 4.  Recommendations for transfusion therapy in neonatology.

Authors:  Gabriella Girelli; Stefano Antoncecchi; Anna Maria Casadei; Antonio Del Vecchio; Paola Isernia; Mario Motta; Daniela Regoli; Costantino Romagnoli; Gino Tripodi; Claudio Velati
Journal:  Blood Transfus       Date:  2015-07       Impact factor: 3.443

5.  A multidisciplinary "think tank": the top 10 clinical trial opportunities in transfusion medicine from the National Heart, Lung, and Blood Institute-sponsored 2009 state-of-the-science symposium.

Authors:  Cassandra D Josephson; Simone A Glynn; Steve H Kleinman; Morris A Blajchman
Journal:  Transfusion       Date:  2010-10-04       Impact factor: 3.157

6.  Acute physiological effects of packed red blood cell transfusion in preterm infants with different degrees of anaemia.

Authors:  Laura K Fredrickson; Edward F Bell; Gretchen A Cress; Karen J Johnson; M Bridget Zimmerman; Larry T Mahoney; John A Widness; Ronald G Strauss
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2010-11-20       Impact factor: 5.747

7.  Commentary: is it safe to limit allogeneic red blood cell transfusions to neonates?

Authors:  Ronald G Strauss
Journal:  Neonatology       Date:  2007-11-16       Impact factor: 4.035

8.  A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia.

Authors:  Matthew R Rosebraugh; John A Widness; Demet Nalbant; Peter Veng-Pedersen
Journal:  Transfusion       Date:  2012-10-04       Impact factor: 3.157

9.  Pharmacodynamically optimized erythropoietin treatment combined with phlebotomy reduction predicted to eliminate blood transfusions in selected preterm infants.

Authors:  Matthew R Rosebraugh; John A Widness; Demet Nalbant; Gretchen Cress; Peter Veng-Pedersen
Journal:  Pediatr Res       Date:  2013-11-11       Impact factor: 3.756

10.  Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.

Authors:  Robin K Ohls; Beena D Kamath-Rayne; Robert D Christensen; Susan E Wiedmeier; Adam Rosenberg; Janell Fuller; Conra Backstrom Lacy; Mahshid Roohi; Diane K Lambert; Jill J Burnett; Barbara Pruckler; Hannah Peceny; Daniel C Cannon; Jean R Lowe
Journal:  Pediatrics       Date:  2014-05-12       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.